Literature DB >> 19273061

Tumorigenesis and anti-tumor immune responses in Xenopus.

Ana Goyos1, Jacques Robert.   

Abstract

Despite intense study, the role of the immune system in detecting (immunosurveillance), controlling and remodeling (immunoediting) neoplasia remains elusive. We present here a comparative view of the complex interactions between neoplasia and the host immune system. We provide evidence, in the amphibian Xenopus laevis, consistent with an evolutionarily conserved and crucial role of the immune system in controlling neoplasia, which involves a striking variety of anti-tumoral immune effectors including conventional CTLs, classical MHC class Ia unrestricted CTLs (CCU-CTLs) that interact with nonclassical MHC class Ib molecules, CD8 NKT-like cells and NK cells. We also review the tumors found in X. laevis with an emphasis on thymic lymphoid tumors and a rare ovarian dysgerminoma. Finally, we consider the use of X. laevis for in vivo study of tumorigenesis. Given our current knowledge, the experimental systems already established in X. laevis, and the rapid accumulation of genetic resources for the sister species Silurana (Xenopus) tropicalis, it is our conviction that these species provide an ideal alternative to the murine system for studying tumorigenesis and tumor immunity.

Entities:  

Mesh:

Year:  2009        PMID: 19273061      PMCID: PMC2749489          DOI: 10.2741/3238

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  53 in total

1.  NKT cells and tumor immunity--a double-edged sword.

Authors:  M J Smyth; D I Godfrey
Journal:  Nat Immunol       Date:  2000-12       Impact factor: 25.606

2.  Spontaneous neoplasms in Amphibia: a review and descriptions of six new cases.

Authors:  M BALLS
Journal:  Cancer Res       Date:  1962-11       Impact factor: 12.701

Review 3.  c-Myc, genome instability, and tumorigenesis: the devil is in the details.

Authors:  M Wade; G M Wahl
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

4.  Expression of homologues for p53 and p73 in the softshell clam (Mya arenaria), a naturally-occurring model for human cancer.

Authors:  M L Kelley; P Winge; J D Heaney; R E Stephens; J H Farell; R J Van Beneden; C L Reinisch; M P Lesser; C W Walker
Journal:  Oncogene       Date:  2001-02-08       Impact factor: 9.867

Review 5.  The concept of immunological surveillance.

Authors:  F M Burnet
Journal:  Prog Exp Tumor Res       Date:  1970

Review 6.  Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?

Authors:  Jack D Bui; Robert D Schreiber
Journal:  Curr Opin Immunol       Date:  2007-02-09       Impact factor: 7.486

Review 7.  Lucké renal adenocarcinoma, an anuran neoplasm: studies at the interface of pathology, virology, and differentiation competence.

Authors:  R G McKinnell; D L Carlson
Journal:  J Cell Physiol       Date:  1997-11       Impact factor: 6.384

8.  Ovarian dysgerminomas in two mountain chicken frogs (Leptodactylus fallax).

Authors:  Scott D Fitzgerald; Ann E Duncan; Chris Tabaka; Michael M Garner; April Dieter; Matti Kiupel
Journal:  J Zoo Wildl Med       Date:  2007-03       Impact factor: 0.776

Review 9.  Diversity of the FcR- and KIR-related genes in an amphibian Xenopus.

Authors:  Sergey V Guselnikov; Thaminda Ramanayake; Jacques Robert; Alexander V Taranin
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

10.  Lymphoid tumors of Xenopus laevis with different capacities for growth in larvae and adults.

Authors:  J Robert; C Guiet; L Du Pasquier
Journal:  Dev Immunol       Date:  1994
View more
  16 in total

Review 1.  The genus Xenopus as a multispecies model for evolutionary and comparative immunobiology of the 21st century.

Authors:  Jacques Robert; Nicholas Cohen
Journal:  Dev Comp Immunol       Date:  2011-01-28       Impact factor: 3.636

Review 2.  Innate immunity in vertebrates: an overview.

Authors:  Mario Riera Romo; Dayana Pérez-Martínez; Camila Castillo Ferrer
Journal:  Immunology       Date:  2016-04-05       Impact factor: 7.397

3.  Impacts of the MHC class I-like XNC10 and innate-like T cells on tumor tolerance and rejection in the amphibian Xenopus.

Authors:  Maureen Banach; Eva-Stina Edholm; Xavier Gonzalez; Abdellatif Benraiss; Jacques Robert
Journal:  Carcinogenesis       Date:  2019-07-20       Impact factor: 4.944

4.  A Glimpse of the Peptide Profile Presentation by Xenopus laevis MHC Class I: Crystal Structure of pXela-UAA Reveals a Distinct Peptide-Binding Groove.

Authors:  Lizhen Ma; Nianzhi Zhang; Zehui Qu; Ruiying Liang; Lijie Zhang; Bing Zhang; Geng Meng; Johannes M Dijkstra; Shen Li; Max Chun Xia
Journal:  J Immunol       Date:  2019-11-27       Impact factor: 5.422

Review 5.  The phylogenetic origins of natural killer receptors and recognition: relationships, possibilities, and realities.

Authors:  Jeffrey A Yoder; Gary W Litman
Journal:  Immunogenetics       Date:  2010-12-30       Impact factor: 2.846

6.  Pancreatic carcinoma in an African clawed frog (Xenopus laevis).

Authors:  Adam W Stern; Sarah O Allison; Caroline Chu
Journal:  Comp Med       Date:  2014-12       Impact factor: 0.982

7.  Novel nonclassical MHC class Ib genes associated with CD8 T cell development and thymic tumors.

Authors:  Ana Goyos; Yuko Ohta; Sergey Guselnikov; Jacques Robert
Journal:  Mol Immunol       Date:  2009-02-23       Impact factor: 4.407

8.  Collagenoma in an African Clawed Frog (Xenopus laevis).

Authors:  Jessica M Johnston; Blythe H Philips; Anthony J Carty; Peter S Klein; Angela K Brice
Journal:  Comp Med       Date:  2016-02       Impact factor: 0.982

Review 9.  Comparative and developmental study of the immune system in Xenopus.

Authors:  Jacques Robert; Yuko Ohta
Journal:  Dev Dyn       Date:  2009-06       Impact factor: 3.780

10.  Exploring the functions of nonclassical MHC class Ib genes in Xenopus laevis by the CRISPR/Cas9 system.

Authors:  Maureen Banach; Eva-Stina Edholm; Jacques Robert
Journal:  Dev Biol       Date:  2016-06-16       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.